nagene
products
Precision in every gene, innovation in every step – offering customer-focused, flexible solutions, all manufactured and quality tested in Austria.
Plasmid (pDNA)
The following table shows an estimate of our special express production times, based on non-complex sequences of up to 1500 base pairs.
| Scale | Culture volume | Yield | BSE/TSE & Endotoxin Free | TAT 5 days |
| Mini Prep | 1 mL - 5mL | 1 μg - 3 μg | ||
| Mini Prep | 50 mL - 100 mL | 15 μg - 50 μg | ||
| Maxi Prep | 100 mL - 250 mL | 100 μg - 500 μg | ||
| Mega Prep | 0.5 L - 2.5 L | 500 μg - 2.5 mg | ||
| Giga Prep | 2.5 L | 2.5 mg - 10 mg | +1 day | |
| High Scale | > 10 mg on request |
| Definition of Complexity | |
| GC rich sequences | starting from 75% |
| Hairpin structure | 25 bp |
| Direct repeats | 25 bp |
| Specification | |
| 100 bp - 10000 bp, larger on request | |
| Vectors: Customized | |
| Biosafety level 1 | |
| Concentration: Adjustment on request | |
| Linearization possible |
Process from
Start to Finish
Capacity in 2024 = 12 genes/day (1500 bp)
Capacity in 2025 = 64 genes/day (1500 bp)
Quality Control Methods
| Method | Specification |
| Appearance | No visible particle, clear solution |
| Restriction digest | Expected digest pattern |
| Complete plasmid DNA sequencing (NGS) | Expected Sequence |
| DNA concentration, UV 260 | Target concentration ± 15% (1 μg/μl) |
| Purity, UV 260/280 | 1.6 – 2.0 |
| Host cell protein | < 10 μg/mg |
| Residual Host DNA | < 5% total DNA |
| Method | Specification |
| Homogenity | > 80% supercoiled |
| Endotoxin | ≤ 0.1 EU/μg |
| Bioburden | < 1 CFU/ml |
| Mycoplasma | Absence |
Product
Documentation
- Batchrecord
- Certificate of Conformance
- Quality Report
- Certificate of Analysis